CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 2P56-21 02P56-21

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-11-02 for CLINICAL CHEMISTRY LACTATE DEHYDROGENASE 2P56-21 02P56-21 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[91460850] An abbott field technician visited the customer site to review the issue with the customer. The reagent was replaced and placed in a different position on the analyzer. The water quality was checked and found to be acceptable. The sample diluent was also replaced and the customer informed to replace daily. Subsequent instrument operations and test results were acceptable. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. No returns were made available from the customer site. Instrument logs and history files were reviewed as stored in the architect c16000 analyzer for the clin chem ldh assay. The assay curve pattern was unremarkable and similar to other curves. From (b)(6) 2017, sixty instances of aspiration error codes were logged along with twenty-four instances of incomplete cuvette washing error codes. Sample handling and/or sample integrity issues cannot be ruled out as possible causes of the customer issue as well as incomplete instrument maintenance. The architect clinical chemistry ldh assay package insert and the architect operations manual contains information to address the current customer issue. Based on the available information from the customer site and the results of this evaluation, there is no evidence to reasonably suggest a systemic issue or product deficiency exists.
Patient Sequence No: 1, Text Type: N, H10


[91460851] On (b)(6) 2017, the following architect clin chem assay results were generated on an architect c16000 analyzer: (b)(6): initial result of 237 u/l that retested at 191 u/l. (b)(6): initial result of 279 u/l that retested at 207 u/l. The customer uses a normal reference range of 125 to 220 u/l. The customer will begin testing all samples for ldh in duplicate. No suspect results were reported from the lab. There is no impact to patient care reported. A service call was initiated.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1628664-2017-00414
MDR Report Key6995744
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-11-02
Date of Report2017-11-02
Date of Event2017-10-16
Date Mfgr Received2017-10-19
Device Manufacturer Date2017-03-21
Date Added to Maude2017-11-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY LACTATE DEHYDROGENASE
Generic NameLACTATE DEHYDROGENASE
Product CodeCFJ
Date Received2017-11-02
Model Number2P56-21
Catalog Number02P56-21
Lot Number36251UN17
Device Expiration Date2018-01-06
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2017-11-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.